JW Pharmaceutical Corp Cash Flow Conversion Efficiency

Latest as of September 2025: 0.132x

JW Pharmaceutical Corp cash flow conversion efficiency. Based on the latest financial reports, JW Pharmaceutical Corp (001067) has a cash flow conversion efficiency ratio of 0.132x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩46.92 Billion ≈ $31.79 Million USD) by net assets (₩354.10 Billion ≈ $239.97 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of JW Pharmaceutical Corp (2014–2024)

Cash flow conversion efficiency of JW Pharmaceutical Corp from 2014 to 2024. This chart illustrates how JW Pharmaceutical Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data. View JW Pharmaceutical Corp (001067) stock price for real-time trading data and today's change.

JW Pharmaceutical Corp Cash Flow Conversion Ratio Explained

JW Pharmaceutical Corp cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

JW Pharmaceutical Corp Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of JW Pharmaceutical Corp ranked by their cash flow conversion efficiency. Also see how much is JW Pharmaceutical Corp worth for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Data Storage Corp NASDAQ:DTST	-0.086x
JPMorgan European Growth & Income plc LSE:JEGI	0.004x
Fly Play hf. IC:PLAY	N/A
Bon Natural Life Ltd NASDAQ:BON	0.076x
Burford Capital Limited LSE:BUR	0.048x
PT Mitra Pack Tbk JK:PTMP	-0.087x
Hube Yangfan Holding Co Ltd SHG:600421	-0.156x
Diamond Estates Wines & Spirits Inc V:DWS	-0.017x

Annual Cash Flow Conversion Efficiency for JW Pharmaceutical Corp (2014–2024)

The table below shows the annual cash flow conversion efficiency of JW Pharmaceutical Corp from 2014 to 2024. Review JW Pharmaceutical Corp (001067) FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩329.49 Billion ≈ $223.29 Million	₩79.39 Billion ≈ $53.80 Million	0.241x	-26.62%
2023-12-31	₩265.44 Billion ≈ $179.89 Million	₩87.16 Billion ≈ $59.07 Million	0.328x	+30.59%
2022-12-31	₩225.76 Billion ≈ $152.99 Million	₩56.76 Billion ≈ $38.47 Million	0.251x	+161.57%
2021-12-31	₩188.54 Billion ≈ $127.77 Million	₩18.12 Billion ≈ $12.28 Million	0.096x	-68.37%
2020-12-31	₩207.47 Billion ≈ $140.60 Million	₩63.05 Billion ≈ $42.73 Million	0.304x	+25.93%
2019-12-31	₩230.09 Billion ≈ $155.93 Million	₩55.53 Billion ≈ $37.63 Million	0.241x	+20.47%
2018-12-31	₩260.11 Billion ≈ $176.27 Million	₩52.11 Billion ≈ $35.31 Million	0.200x	+62.17%
2017-12-31	₩270.78 Billion ≈ $183.50 Million	₩33.45 Billion ≈ $22.67 Million	0.124x	+406.54%
2016-12-31	₩276.31 Billion ≈ $187.25 Million	₩6.74 Billion ≈ $4.57 Million	0.024x	+231.67%
2015-12-31	₩225.41 Billion ≈ $152.75 Million	₩-4.17 Billion ≈ $-2.83 Million	-0.019x	-155.99%
2014-12-31	₩220.02 Billion ≈ $149.11 Million	₩7.28 Billion ≈ $4.93 Million	0.033x	--

About JW Pharmaceutical Corp

KO:001067 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$6.87 Million

₩10.14 Billion KRW

Market Cap Rank

#27821 Global

#2050 in Korea

Share Price

₩49050.00

Change (1 day)

-0.10%

52-Week Range

₩41000.00 - ₩61500.00

All Time High

₩131401.16